Current status of gadolinium toxicity in patients with kidney disease

Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Grobner, T. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk062 · Cited by 1,862 · see citing works

Nephrogenic Systemic Fibrosis

Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M. B., Heaf, J. G., & Thomsen, H. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060601 · Cited by 1,398 · see citing works

Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation

Sadowski, E. A., Bennett, L. K., Chan, M. R., Wentland, A. L., Garrett, A. L., Garrett, R. W., & Djamali, A. (2007) · Radiology · doi:10.1148/radiol.2431062144 · Cited by 1,011 · see citing works

Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned

Broome, D. R., Girguis, M. S., Baron, P. W., Cottrell, A. C., Kjellin, I. B., & Kirk, G. A. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1094 · Cited by 599 · see citing works

Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis

High, W. A., Ayers, R. A., Chandler, J. P., Zito, G., & Cowper, S. E. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.047 · Cited by 542 · see citing works

Nephrogenic Fibrosing Dermopathy

Cowper, S. E., Su, L. D., Bhawan, J., Robin, H. S., & LeBoit, P. E. (2001) · American Journal of Dermatopathology · doi:10.1097/00000372-200110000-00001 · Cited by 473 · see citing works

Nephrotoxicity of high‐dose gadolinium compared with iodinated contrast

Prince, M. R., Arnoldus, C. L., & Frisoli, J. K. (1996) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880060129 · Cited by 401 · see citing works

Gadolinium deposition in nephrogenic fibrosing dermopathy

Boyd, A. S., Zic, J. A., & Abraham, J. L. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.048 · Cited by 374 · see citing works

Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide

Thomsen, H. S. (2006) · European Radiology · doi:10.1007/s00330-006-0495-8 · Cited by 352 · see citing works

Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy Cohort

Collidge, T., Thomson, P. C., Mark, P. B., Traynor, J. P., Jardine, A. G., Morris, S., Simpson, K., & Roditi, G. (2007) · Radiology · doi:10.1148/radiol.2451070353 · Cited by 319 · see citing works

Community-acquired methicillin-resistant Staphylococcus aureus

Elston, D. M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.04.018 · Cited by 307 · see citing works

Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting

Broome, D. R. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.02.011 · Cited by 283 · see citing works

Nephrogenic Systemic Fibrosis

Deo, A., Fogel, M., & Cowper, S. E. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03921106 · Cited by 259 · see citing works

High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast Agent

Rydahl, C., Thomsen, H. S., & Marckmann, P. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e31815a3407 · Cited by 252 · see citing works

MR contrast agents, the old and the new

Bellin, M. (2006) · European Journal of Radiology · doi:10.1016/j.ejrad.2006.06.021 · Cited by 247 · see citing works

Safety of gadolinium contrast angiography in patients with chronic renal insufficiency

Sam, A. D., Morasch, M. D., Collins, J. D., Song, G. K., Chen, R., & Pereles, F. S. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00315-x · Cited by 210 · see citing works

Case-control study of gadodiamide-related nephrogenic systemic fibrosis

Marckmann, P., Skov, L., Rossen, K., Heaf, J. G., & Thomsen, H. S. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm261 · Cited by 203 · see citing works

Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions

Sieber, M. A., Lengsfeld, P., Frenzel, T., Golfier, S., Schmitt‐Willich, H., Siegmund, F., Walter, J., Weinmann, H., & Pietsch, H. (2008) · European Radiology · doi:10.1007/s00330-008-0977-y · Cited by 203 · see citing works

Risk of Nephrogenic Systemic Fibrosis: Evaluation of Gadolinium Chelate Contrast Agents at Four American Universities

Wertman, R., Altun, E., Martín, D. R., Mitchell, D. G., Leyendecker, J. R., O'Malley, R. B., Parsons, D. J., Fuller, E. R., & Semelka, R. C. (2008) · Radiology · doi:10.1148/radiol.2483072093 · Cited by 186 · see citing works

Nephrogenic Systemic Fibrosis

Shamam, Y. M., & Jesús, O. D. (2021) · StatPearls · Cited by 181 · see citing works

Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)

Galan, A., Cowper, S. E., & Bucala, R. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000245725.94887.8d · Cited by 163 · see citing works

The safety of gadolinium in patients with stage 3 and 4 renal failure

Ergün, İ., Keven, K., Uruç, I., Ekmekçi, Y., Canbakan, B., Erden, İ., & Karatan, O. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi304 · Cited by 157 · see citing works

Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?

Thomsen, H. S., Morcos, S. K., & Dawson, P. (2006) · Clinical Radiology · doi:10.1016/j.crad.2006.09.003 · Cited by 153 · see citing works

Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure

Othersen, J. B., Maize, J. C., Woolson, R. F., & Budisavljevic, M. N. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm584 · Cited by 118 · see citing works

Safety of Magnetic Resonance Contrast Media

Runge, V. M. (2001) · Topics in Magnetic Resonance Imaging · doi:10.1097/00002142-200108000-00007 · Cited by 116 · see citing works

Risk for Nephrogenic Systemic Fibrosis with Gadoteridol (ProHance) in Patients Who Are on Long-Term Hemodialysis

Reilly, R. F. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05721207 · Cited by 107 · see citing works

Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients

Erley, C. M. M., Bader, B. D., Berger, E. D., Tuncel, N., Winkler, S., Tepe, G., Risler, T., & Duda, S. H. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh272 · Cited by 104 · see citing works

Nephrogenic Systemic Fibrosis, Kidney Disease, and Gadolinium

Perazella, M. A. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00030107 · Cited by 104 · see citing works

Safety and Pharmacokinetic Profile of Gadobenate Dimeglumine in Subjects With Renal Impairment

Swan, S. K., Lambrecht, L. J., Townsend, R. R., DAVIES, B. E., McCLOUD, S., PARKER, J. R., Bensel, K. S., & LaFrance, N. D. (1999) · Investigative Radiology · doi:10.1097/00004424-199907000-00001 · Cited by 97 · see citing works

Gadolinium‐based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures

Briguori, C., Colombo, A., Airoldi, F., Melzi, G., Michev, I., Carlino, M., Montorfano, M., Chieffo, A., Bellanca, R., & Ricciardelli, B. (2006) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.20592 · Cited by 95 · see citing works

Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function

Rieger, J. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.5.824 · Cited by 93 · see citing works

Editorial: Gadolinium Use in Patients with Kidney Disease: A Cause for Concern

Perazella, M. A., & Rodby, R. A. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00269.x · Cited by 92 · see citing works

Systemic Gadolinium Toxicity in Patients With Renal Insufficiency and Renal Failure: Retrospective Analysis of an Initial Experience

Arsenault, T. M., King, B. F., Marsh, J. W., Goodman, J. A., Weaver, A. L., Wood, C. P., & Ehman, R. L. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.12.1150 · Cited by 81 · see citing works

Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography

Hammer, F., Goffette, P. P., Malaise, J., & Mathurin, P. (1999) · European Radiology · doi:10.1007/s003300050643 · Cited by 78 · see citing works

Ultrastructural Evidence of Dermal Gadolinium Deposits in a Patient with Nephrogenic Systemic Fibrosis and End-Stage Renal Disease

Schroeder, J. A., Weingart, C., Coras, B., Haußer, I., Reinhold, S. W., Mack, M., Seybold, V., VOGT, T. M., Banas, B., Hofstaedter, F., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00100108 · Cited by 76 · see citing works

Lower Extremity Arteriography with Use of Iodinated Contrast Material or Gadodiamide to Supplement CO2 Angiography in Patients with Renal Insufficiency

Spinosa, D. J., Angle, J. F., Hagspiel, K. D., Kern, J. A., Hartwell, G. D., & Matsumoto, A. H. (2000) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(07)61275-5 · Cited by 69 · see citing works

Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes

Kane, G. C., Stanson, A. W., Kalnická, D., Rosenthal, D. W., Lee, C. U., Textor, S. C., & Garovic, V. D. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm725 · Cited by 53 · see citing works

GD-DOTA: Evaluation of its renal tolerance in patients with chronic renal failure

Bellin, M., Deray, G., Assogba, U., Auberton, E., Ghany, F., Dion, É., Jacobs, C., & Grellet, J. (1992) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(92)90380-i · Cited by 47 · see citing works

Magnetic Resonance Contrast Agents: From the Bench to the Patient

Lorusso, V., Pascolo, L., Fernetti, C., Anelli, P. L., Uggeri, F., & Tiribelli, C. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774913336 · Cited by 40 · see citing works

Toxicological Assessment of Gadoversetamide Injection (OptiMARK®), a New Contrast-Enhancement Agent for Use in Magnetic Resonance Imaging

Wible, J. H., Troup, C. M., Hynes, M. R., Galen, K. P., MacDONALD, J. R., BARCO, S. J., Wojdyla, J. K., Periasamy, M., & ADAMS, M. D. (2001) · Investigative Radiology · doi:10.1097/00004424-200107000-00006 · Cited by 38 · see citing works

Safety of CO2- and Gadodiamide-Enhanced Angiography for the Evaluation and Percutaneous Treatment of Renal Artery Stenosis in Patients with Chronic Renal Insufficiency

Spinosa, D. J., Matsumoto, A. H., Angle, J. F., Hagspiel, K. D., Cage, D. L., Bissonette, E. A., Koenig, K. G., Ayers, C. R., & McConnell, K. N. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.176.5.1761305 · Cited by 38 · see citing works

Gadodiamide as an Alternative Contrast Agent in Intravenous Digital Subtraction Angiography and Interventional Procedures of the Upper Extremity Veins

Sancak, T., Bilgic, S., & Sanldilek, U. (2002) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-001-0083-x · Cited by 20 · see citing works

Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications

Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181 · see citing works

X-ray-Computed Tomography Contrast Agents

Lusic, H., & Grinstaff, M. W. (2012) · Chemical Reviews · doi:10.1021/cr200358s · Cited by 1,118 · see citing works

Nanomaterials for In Vivo Imaging

Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,076 · see citing works

ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance

Hundley, W. G., Bluemke, D. A., Finn, J. P., Flamm, S. D., Fogel, M. A., Friedrich, M. G., Ho, V. B., Jerosch‐Herold, M., Kramer, C. M., Manning, W. J., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d44a8f · Cited by 822 · see citing works

Upconverting nanoparticles: assessing the toxicity

Gnach, A., Lipiński, T., Bednarkiewicz, A., Rybka, J., & Capobianco, J. A. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00177j · Cited by 655 · see citing works

ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance

Hundley, W. G., Bluemke, D. A., Finn, J. P., Flamm, S. D., Fogel, M. A., Friedrich, M. G., Ho, V. B., Jerosch‐Herold, M., Kramer, C. M., Manning, W. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.011 · Cited by 591 · see citing works

Gadolinium‐based contrast agents for magnetic resonance cancer imaging

Zhou, Z., & Lu, Z. (2012) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1198 · Cited by 431 · see citing works

Clinical Practice Guideline: Ménière’s Disease

Basura, G. J., Adams, M. E., Monfared, A. S., Schwartz, S., Antonelli, P. J., Burkard, R. F., Bush, M. L., Bykowski, J., Colandrea, M., Derebery, J. M., et al. (2020) · Otolaryngology · doi:10.1177/0194599820909438 · Cited by 379 · see citing works

Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging

Shen, Z., Wu, A., & Chen, X. S. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00839 · Cited by 326 · see citing works

Dual purpose Prussian blue nanoparticles for cellular imaging and drug delivery: a new generation of T1-weighted MRI contrast and small molecule delivery agents

Shokouhimehr, M., Soehnlen, E. S., Hao, J., Griswold, M. A., Flask, C. A., Fan, X., Basilion, J. P., Basu, S., & Huang, S. D. (2010) · Journal of Materials Chemistry · doi:10.1039/b923184f · Cited by 260 · see citing works

Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

Kamat, A. M., Flaig, T. W., Grossman, H. B., Konety, B. R., Lamm, D. L., O’Donnell, M. A., Uchio, E., Efstathiou, J. A., & Taylor, J. A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.58 · Cited by 251 · see citing works

Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle

Huang, Y., Hsu, J. C., Koo, H., & Cormode, D. P. (2021) · Theranostics · doi:10.7150/thno.67375 · Cited by 259 · see citing works

Multifunctional Fe3O4/TaOxCore/Shell Nanoparticles for Simultaneous Magnetic Resonance Imaging and X-ray Computed Tomography

Lee, N., Cho, H. R., Oh, M. H., Lee, S. H., Kim, K. M., Kim, B. H., Shin, K., Ahn, T.-Y., Choi, J. W., Kim, Y., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3016582 · Cited by 236 · see citing works

Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2)

Lameire, N. H., Kellum, J. A., & for the KDIGO AKI Guideline Work Group (2013) · Critical Care · doi:10.1186/cc11455 · Cited by 220 · see citing works

Impact of Lanthanide Nanomaterials on Photonic Devices and Smart Applications

Zhou, J., Leaño, J. L., Liu, Z., Jin, D., Wong, K., Liu, R., & Bünzli, J. G. (2018) · Small · doi:10.1002/smll.201801882 · Cited by 166 · see citing works

Large‐Scale Synthesis and Medical Applications of Uniform‐Sized Metal Oxide Nanoparticles

Kwon, H. J., Shin, K., Soh, M., Chang, H., Kim, J., Lee, J., Ko, G., Kim, B. H., Kim, D., & Hyeon, T. (2018) · Advanced Materials · doi:10.1002/adma.201704290 · Cited by 161 · see citing works

Macromolecular Ligands for Gadolinium MRI Contrast Agents

Li, Y., Beija, M., Laurent, S., Elst, L. V., Müller, R. N., Duong, H. T. T., Lowe, A. B., Davis, T. P., & Boyer, C. A. (2012) · Macromolecules · doi:10.1021/ma300521c · Cited by 151 · see citing works

Hybrid Calcium Phosphate-Polymeric Micelles Incorporating Gadolinium Chelates for Imaging-Guided Gadolinium Neutron Capture Tumor Therapy

Mi, P., Dewi, N., Yanagië, H., Kokuryo, D., Suzuki, M., Sakurai, Y., Li, Y., Aoki, I., Ono, K., Takahashi, H., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b00532 · Cited by 141 · see citing works

Contrast-induced acute kidney injury: A review of practical points

Özkök, S., & Özkök, A. (2017) · World Journal of Nephrology · doi:10.5527/wjn.v6.i3.86 · Cited by 139 · see citing works

Progress and prospects of magnetic iron oxide nanoparticles in biomedical applications: A review

Elahi, N., & Rizwan, M. (2021) · Artificial Organs · doi:10.1111/aor.14027 · Cited by 129 · see citing works

Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution

Do, C., DeAguero, J., Brearley, A., Trejo, X., Howard, T., Escobar, G. P., & Wagner, B. (2020) · Kidney360 · doi:10.34067/kid.0000272019 · Cited by 125 · see citing works

Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration

Davies, J., Siebenhandl-Wolff, P., Tranquart, F., Jones, P. A., & Evans, P. M. (2022) · Archives of Toxicology · doi:10.1007/s00204-021-03189-8 · Cited by 123 · see citing works

Recent development of nanoparticles for molecular imaging

Kim, J., Lee, N., & Hyeon, T. (2017) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2017.0022 · Cited by 116 · see citing works

Functional nanoparticles for magnetic resonance imaging

Mao, X., Xu, J., & Cui, H. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1400 · Cited by 111 · see citing works

Dissociation Kinetics of Open‐Chain and Macrocyclic Gadolinium(III)‐Aminopolycarboxylate Complexes Related to Magnetic Resonance Imaging: Catalytic Effect of Endogenous Ligands

Baranyai, Z., Pálinkás, Z., Uggeri, F., Maiocchi, A., Aime, S., & Brücher, E. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201202930 · Cited by 109 · see citing works

Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease

Knuuti, J. M., Bengel, F. M., Bax, J. J., Kaufmann, P. A., Guludec, D. L., Filardi, P. P., Marcassa, C., Marsan, N. A., Achenbach, S. S., Kitsiou, A. N., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht512 · Cited by 107 · see citing works

Advanced metal and carbon nanostructures for medical, drug delivery and bio-imaging applications

Kumar, N., Chamoli, P., Misra, M., Manoj, M. K., & Sharma, A. (2022) · Nanoscale · doi:10.1039/d1nr07643d · Cited by 98 · see citing works

New Insight about Biocompatibility and Biodegradability of Iron Oxide Magnetic Nanoparticles: Stereological and In Vivo MRI Monitor

Nosrati, H., Salehiabar, M., Fridoni, M., Abdollahifar, M., Manjili, H. K., Davaran, S., & Danafar, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-43650-4 · Cited by 96 · see citing works

Iron Oxide Nanoparticles in Bioimaging – An Immune Perspective

Geppert, M., & Himly, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688927 · Cited by 93 · see citing works

Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis

Lau, J. F., Weinberg, M. D., & Olin, J. W. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.66 · Cited by 93 · see citing works

Involvement of Gadolinium Chelates in the Mechanism of Nephrogenic Systemic Fibrosis: An Update

Idée, J., Port, M., Dencausse, A., Lancelot, E., & Corot, C. (2009) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2009.06.006 · Cited by 90 · see citing works

Effect of r1 and r2 relaxivity of gadolinium‐based contrast agents on the T1‐weighted MR signal at increasing magnetic field strengths

Hagberg, G. E., & Scheffler, K. (2013) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1565 · Cited by 89 · see citing works

Review of breast screening: Toward clinical realization of microwave imaging

Modiri, A., Goudreau, S., Rahimi, A. S., & Kıasaleh, K. (2017) · Medical Physics · doi:10.1002/mp.12611 · Cited by 87 · see citing works

Comparative study of the effects of gadolinium chloride and gadolinium – based magnetic resonance imaging contrast agent on freshwater mussel, Dreissena polymorpha

Hanana, H., Turcotte, P., André, C., Gagnon, C., & Gagné, F. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.04.073 · Cited by 82 · see citing works

Triply Loaded Nitroxide Brush-Arm Star Polymers Enable Metal-Free Millimetric Tumor Detection by Magnetic Resonance Imaging

Nguyen, H. V. ‐., Detappe, A., Gallagher, N. M., Zhang, H., Harvey, P., Yan, C., Mathieu, C., Golder, M. R., Jiang, Y., Ottaviani, M. F., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b06160 · Cited by 81 · see citing works

Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults

Muehe, A. M., Feng, D., von Eyben, R., Luna‐Fineman, S., Link, M. P., Muthig, T., Huddleston, A. E., Neuwelt, E. A., & Daldrup-Link, H. E. (2015) · Investigative Radiology · doi:10.1097/rli.0000000000000230 · Cited by 80 · see citing works

Perspectives and challenges of photon-upconversion nanoparticles - Part II: bioanalytical applications

Gorris, H. H., & Resch‐Genger, U. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0482-8 · Cited by 77 · see citing works

Functional polymers as metal-free magnetic resonance imaging contrast agents

Fu, C., Yu, Y., Xu, X., Wang, Q., Chang, Y.-X., Zhang, C., Zhao, J., Peng, H., & Whittaker, A. K. (2020) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2020.101286 · Cited by 75 · see citing works

Section 4: Contrast-induced AKI

(2012) · Kidney International Supplements · doi:10.1038/kisup.2011.34 · Cited by 68 · see citing works

Glutathione (GSH) Peptide Conjugated Magnetic Nanoparticles As Blood–Brain Barrier Shuttle for MRI-Monitored Brain Delivery of Paclitaxel

Nosrati, H., Tarantash, M., Bochani, S., Charmi, J., Bagheri, Z., Fridoni, M., Abdollahifar, M., Davaran, S., Danafar, H., & Manjili, H. K. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01420 · Cited by 66 · see citing works

Importance of monitoring renal function in patients with cancer

Aapro, M., & Launay‐Vacher, V. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.05.001 · Cited by 64 · see citing works

Optimal wavelet signal compression as an efficient alternative to investigate molecular dynamics simulations: application to thermal and solvent effects of MRI probes

Gonçalves, M. A., Santos, L. D. S., Prata, D. M., Peixoto, F. C., da Cunha, E. F. F., & Ramalho, T. C. (2016) · Theoretical Chemistry Accounts · doi:10.1007/s00214-016-2037-z · Cited by 65 · see citing works

Stem cell–nanomedicine system as a theranostic bio-gadolinium agent for targeted neutron capture cancer therapy

Lai, Y., Su, C.-Y., Cheng, H., Chu, C., Jeng, L., Chiang, C., Shyu, W., & Chen, S. (2023) · Nature Communications · doi:10.1038/s41467-023-35935-0 · Cited by 65 · see citing works

Photoacoustic computed tomography of human extremities

Wray, P. R., Lin, L., Hu, P., & Wang, L.-H. V. (2019) · Journal of Biomedical Optics · doi:10.1117/1.jbo.24.2.026003 · Cited by 62 · see citing works

An all-in-one nanoparticle (AION) contrast agent for breast cancer screening with DEM-CT-MRI-NIRF imaging

Hsu, J. C., Naha, P. C., Lau, K. C., Chhour, P., Hastings, R., Moon, B. F., Stein, J. M., Witschey, W. R. T., McDonald, E. S., Maidment, A. D. A., et al. (2018) · Nanoscale · doi:10.1039/c8nr03741h · Cited by 63 · see citing works

Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD

(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.67 · Cited by 61 · see citing works

Nanomedical Theranostics in Cardiovascular Disease

Tang, J., Lobatto, M. E., Read, J. C., Mieszawska, A. J., Fayad, Z. A., & Mulder, W. J. M. (2011) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-011-9120-6 · Cited by 58 · see citing works

Blood‐Pool and Targeting MRI Contrast Agents: From Gd‐Chelates to Gd‐Nanoparticles

Lee, G. H., Chang, Y., & Kim, T. (2012) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201101137 · Cited by 57 · see citing works

Dendritic Nanoglobules with Polyhedral Oligomeric Silsesquioxane Core and Their Biomedical Applications

Zhou, Z., & Lu, Z. (2014) · Nanomedicine · doi:10.2217/nnm.14.133 · Cited by 57 · see citing works

Applications of Molecular Mri and Optical Imaging in Cancer

Penet, M., Mikhaylova, M., Li, C., Krishnamachary, B., Glunde, K., Pathak, A. P., & Bhujwalla, Z. M. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.25 · Cited by 56 · see citing works

An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success

Kumbhar, P. R., Kumar, P., Lasure, A., Ravichandiran, V., & Mandal, D. (2023) · Discover Nano · doi:10.1186/s11671-023-03913-6 · Cited by 58 · see citing works

Clinical, Biological, and Skin Histopathologic Effects of Ionic Macrocyclic and Nonionic Linear Gadolinium Chelates in a Rat Model of Nephrogenic Systemic Fibrosis

Fretellier, N., Idée, J., Guérret, S., Hollenbeck, C., Hartmann, D. J., González, W., Pujolle-Robic, C., Port, M., & Corot, C. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181f54044 · Cited by 55 · see citing works

Nanoparticles Based on Star Polymers as Theranostic Vectors: Endosomal‐Triggered Drug Release Combined with MRI Sensitivity

Li, Y., Duong, H. T. T., Laurent, S., MacMillan, A., Whan, R. M., Elst, L. V., Müller, R. N., Hu, J., Lowe, A. B., Boyer, C. A., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400164 · Cited by 54 · see citing works

Type of MRI contrast, tissue gadolinium, and fibrosis

Do, C., Barnes, J. L., Tan, C., & Wagner, B. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00379.2014 · Cited by 53 · see citing works

PVP‐coated Gd‐grafted nanodiamonds as a novel and potentially safer contrast agent for in vivo MRI

Panich, A. M., Salti, M., Prager, O., Swissa, E., Kulvelis, Y. V., Yudina, E. B., Aleksenskii, A. E., Goren, S. D., Vul', A. Y., & Shames, A. I. (2021) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28762 · Cited by 53 · see citing works

3-D Microwave Tomography Using the Soft Prior Regularization Technique: Evaluation in Anatomically Realistic MRI-Derived Numerical Breast Phantoms

Golnabi, A. H., Meaney, P. M., Geimer, S. D., & Paulsen, K. D. (2019) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2019.2892303 · Cited by 50 · see citing works

2-Dimensional Nanomaterials with Imaging and Diagnostic Functions for Nanomedicine; A Review

Eom, S., Choi, G., Nakamura, H., & Choy, J. (2019) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20190270 · Cited by 50 · see citing works

Continuous flow Overhauser dynamic nuclear polarization of water in the fringe field of a clinical magnetic resonance imaging system for authentic image contrast

Lingwood, M. D., Siaw, T. A., Sailasuta, N., Ross, B. D., Bhattacharya, P. K., & Han, S. (2010) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2010.05.008 · Cited by 48 · see citing works

Hyperpolarized Water as an MR Imaging Contrast Agent: Feasibility of in Vivo Imaging in a Rat Model

Lingwood, M. D., Siaw, T. A., Sailasuta, N., Abulseoud, O. A., Chan, H. R., Ross, B. D., Bhattacharya, P. K., & Han, S. (2012) · Radiology · doi:10.1148/radiol.12111804 · Cited by 48 · see citing works

Gadolinium based contrast agents (GBCAs): Uniqueness, aquatic toxicity concerns, and prospective remediation

Oluwasola, E. I., Ahmad, A. L., Shoparwe, N. F., & Ismail, S. B. (2022) · Journal of Contaminant Hydrology · doi:10.1016/j.jconhyd.2022.104057 · Cited by 47 · see citing works

Current concepts of contrast-induced nephropathy: A brief review

Chang, C.-F., & Lin, C. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.08.011 · Cited by 47 · see citing works

The precise molecular location of gadolinium atoms has a significant influence on the efficacy of nanoparticulate MRI positive contrast agents

Li, Y., Laurent, S., Esser, L., Elst, L. V., Müller, R. N., Lowe, A. B., Boyer, C. A., & Davis, T. P. (2013) · Polymer Chemistry · doi:10.1039/c3py01676e · Cited by 47 · see citing works

Dedicated Photoacoustic Imaging Instrument for Human Periphery Blood Vessels: A New Paradigm for Understanding the Vascular Health

Chen, T., Liu, L., Ma, X., Zhang, Y., Liu, H., Zheng, R., Ren, J., Zhou, H., Ren, Y., Gao, R., et al. (2021) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2021.3113764 · Cited by 46 · see citing works

Gadolinium toxicity: mechanisms, clinical manifestations, and nanoparticle role

Domingo, J. L., & Semelka, R. C. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04124-x · Cited by 44 · see citing works

Gadolinium-Induced Nephrogenic Systemic Fibrosis

Hellman, R. N. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.05.010 · Cited by 42 · see citing works

Adverse Reactions to Gadoterate Meglumine

de Kerviler, É., Maravilla, K. R., Méder, J.-F., Naggara, O. N., Dubourdieu, C., Jullien, V., & Desché, P. (2016) · Investigative Radiology · doi:10.1097/rli.0000000000000276 · Cited by 42 · see citing works

Kidney and contrast media: Common viewpoint of the French Nephrology societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelines

de Laforcade, L., Bobot, M., Bellin, M., Clémеnt, O., Grangé, S., Grenier, N., Wynckel, A., & Guerrot, D. (2021) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2021.01.007 · Cited by 41 · see citing works

Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use

Cheong, B., Wilson, J. M., Preventza, O. A., & Muthupillai, R. (2022) · Texas Heart Institute Journal · doi:10.14503/thij-21-7680 · Cited by 40 · see citing works

Chapter 5: Referral to specialists and models of care

(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.68 · Cited by 41 · see citing works

References

(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.72 · Cited by 39 · see citing works

Quantification of blood–brain barrier water exchange and permeability with multidelay diffusion‐weighted pseudo‐continuous arterial spin labeling

Shao, X., Zhao, C., Shou, Q., Lawrence, K. S., & Wang, D. J. J. (2023) · Magnetic Resonance in Medicine · doi:10.1002/mrm.29581 · Cited by 37 · see citing works

Measurement of kidney perfusion in critically ill Patients

Schneider, A. G., Goodwin, M. D., & Bellomo, R. (2013) · Critical Care · doi:10.1186/cc12529 · Cited by 36 · see citing works

Optical and Magnetic Resonance Imaging Using Fluorous Colloidal Nanoparticles

Wallat, J. D., Czapar, A. E., Wang, C. Y., Wen, A. M., Wek, K. S., Yu, X., Steinmetz, N. F., & Pokorski, J. K. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b01389 · Cited by 36 · see citing works

Bench-to-bedside development of multifunctional flexible embolic agents

Wang, D., & Rao, W. (2023) · Theranostics · doi:10.7150/thno.80213 · Cited by 35 · see citing works

Evaluation and comparison of diffusion MR methods for measuring apparent transcytolemmal water exchange rate constant

Tian, X., Li, H., Jiang, X., Xie, J., Gore, J. C., & Xu, J. (2016) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2016.11.018 · Cited by 35 · see citing works

How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach

Muehe, A. M., Theruvath, A. J., Lai, L. M., Aghighi, M., Quon, A. S. W., Holdsworth, S. J., Wang, J., Luna‐Fineman, S., Marina, N. M., Advani, R. H., et al. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1105-7 · Cited by 35 · see citing works

Nephrogenic Gadolinium Biodistribution and Skin Cellularity Following a Single Injection of Omniscan in the Rat

Haylor, J., Dencausse, A., Vickers, M. E., Nutter, F., Jestin, G., Slater, D. N., Idée, J., & Morcos, S. K. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181eb51f2 · Cited by 35 · see citing works

Role of magnetic resonance imaging in the detection and characterization of solid pancreatic nodules: An update

Ansari, N. A. (2015) · World Journal of Radiology · doi:10.4329/wjr.v7.i11.361 · Cited by 34 · see citing works

Diagnostic and prognostic value of delayed Gadolinium Enhanced Magnetic Resonance Imaging of Cartilage (dGEMRIC) in early osteoarthritis of the hip

Palmer, A. J. R., Fernquest, S. J., Rombach, I., Park, D., Pollard, T., Broomfield, J., Bangerter, N. K., Carr, A. J., & Glyn‐Jones, S. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.05.004 · Cited by 34 · see citing works

Identifying the Adamkiewicz artery using 3-T time-resolved magnetic resonance angiography: its role in addition to multidetector computed tomography angiography

Takagi, H., Ota, H., Natsuaki, Y., Komori, Y., Ito, K., Saiki, Y., & Takase, K. (2015) · Japanese Journal of Radiology · doi:10.1007/s11604-015-0490-6 · Cited by 34 · see citing works

Integration of 3-Dimensional Scar Models from SPECT to Guide Ventricular Tachycardia Ablation

Tian, J., Smith, M. F., Ahmad, G., Dilsizian, V., Jiménez, A., & Dickfeld, T. M. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.094904 · Cited by 33 · see citing works

Luminophore and Magnetic Multicore Nanoassemblies for Dual-Mode MRI and Fluorescence Imaging

Lartigue, L., Coupeau, M., & Lesault, M. (2019) · Nanomaterials · doi:10.3390/nano10010028 · Cited by 32 · see citing works

Assessment of unilateral ureter obstruction with multi‐parametric MRI

Wang, F., Takahashi, K., Li, H., Zu, Z., Li, K., Xu, J., Harris, R. C., Takahashi, T., & Gore, J. C. (2017) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26849 · Cited by 32 · see citing works

Imaging Shoulder Instability in the Athlete

Bergin, D. (2009) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2009.06.002 · Cited by 31 · see citing works

Management of Adverse Reactions to Iodinated Contrast Media for Computed Tomography in Korean Referral Hospitals: A Survey Investigation

Han, S., Yoon, S. H., Lee, W., Choi, Y. H., Kang, D. Y., & Kang, H. (2018) · Korean Journal of Radiology · doi:10.3348/kjr.2017.0771 · Cited by 31 · see citing works

Engineered upconversion nanocarriers for synergistic breast cancer imaging and therapy: Current state of art

Chintamaneni, P. K., Dasari, N., Katta, C. B., Mourya, A., Madan, J., Srinivasarao, D. A., Ramachandra, R. K., Santhoshi, P. M., & Pindiprolu, S. K. S. S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.056 · Cited by 31 · see citing works

Biocompatible and pH-sensitive MnO-loaded carbonaceous nanospheres (MnO@CNSs): A theranostic agent for magnetic resonance imaging-guided photothermal therapy

Xiang, Y. H., Li, N., Guo, L., Wang, H., Sun, H., Li, R., Ma, L., Qi, Y., Zhan, J., & Yu, D. (2018) · Carbon · doi:10.1016/j.carbon.2018.04.058 · Cited by 31 · see citing works

Imaging For Renovascular Disease

O'Neill, W. C., Bardelli, M., & Yevzlin, A. S. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.05.007 · Cited by 29 · see citing works

Monophosphoryl lipid A as a prophylactic for sepsis and septic shock.

Gustafson, G. L., Rhodes, M. J., & Hegel, T. (1995) · PubMed · Cited by 29 · see citing works

Perspectives on the Role of Magnetic Resonance Imaging (MRI) for Noninvasive Evaluation of Diabetic Kidney Disease

Mora‐Gutiérrez, J. M., Fernández‐Seara, M. A., Echeverría‐Chasco, R., & Garcı́a-Fernández, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112461 · Cited by 29 · see citing works

The issues and tentative solutions for contrast‐enhanced magnetic resonance imaging at ultra‐high field strength

Fries, P., Morelli, J. N., Lux, F., Tillement, O., Schneider, G. K., & Buecker, A. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1291 · Cited by 28 · see citing works

References

(2012) · Kidney International Supplements · doi:10.1038/kisup.2011.38 · Cited by 28 · see citing works

Predicting Breakdown of the Blood-Brain Barrier in Multiple Sclerosis without Contrast Agents

Shinohara, R. T., Goldsmith, J., Mateen, F. J., Crainiceanu, C., & Reich, D. S. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2997 · Cited by 27 · see citing works

Minor changes in the macrocyclic ligands but major consequences on the efficiency of gold nanoparticles designed for radiosensitization

Laurent, G., Bernhard, C., Dufort, S., Sánchez, G. J., Bazzi, R., Boschetti, F., Moreau, M., Vu, T. H., Collin, B., Oudot, A., et al. (2016) · Nanoscale · doi:10.1039/c6nr01228k · Cited by 27 · see citing works

Nephrogenic systemic fibrosis: A frivolous entity

Bhargava, V., Singh, K., Meena, P., & Sanyal, R. (2021) · World Journal of Nephrology · doi:10.5527/wjn.v10.i3.29 · Cited by 26 · see citing works

Raman needle arthroscopy for in vivo molecular assessment of cartilage

Kroupa, K. R., Wu, M. I., Zhang, J., Jensen, M., Wong, W., Engiles, J. B., Schaer, T. P., Grinstaff, M. W., Snyder, B. D., Bergholt, M. S., et al. (2021) · Journal of Orthopaedic Research® · doi:10.1002/jor.25155 · Cited by 26 · see citing works

Imaging Patients With Kidney Disease: How Do We Approach Contrast-Related Toxicity?

Perazella, M. A., & Reilly, R. F. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181f016e6 · Cited by 26 · see citing works

Advanced vascular imaging techniques

Settecase, F., & Rayz, V. L. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64034-5.00016-x · Cited by 25 · see citing works

The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro

Kasper, J. Y., Hermanns, M. I., Cavelius, C., Kraegeloh, A., Jung, T., Danzebrink, R., Unger, R. E., & Kirkpatrick, C. J. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s92608 · Cited by 25 · see citing works

Can Ultrasound With Contrast Enhancement Replace Nonenhanced Computed Tomography Scans in Patients With Contraindication to Computed Tomography Contrast Agents?

Sawhney, S., & Wilson, S. R. (2017) · Ultrasound Quarterly · doi:10.1097/ruq.0000000000000271 · Cited by 25 · see citing works

Mini-Review Current Status of Gadolinium Toxicity in Patients with Kidney

Perazella, M. A. (2015)

Gadolinium-Contrast Toxicity in Patients with Kidney Disease: Nephrotoxicity and Nephrogenic Systemic Fibrosis

Perazella, M. A. (2008) · Current Drug Safety · doi:10.2174/157488608783333989 · Cited by 165 · see citing works

Editorial: Gadolinium Use in Patients with Kidney Disease: A Cause for Concern

Perazella, M. A., & Rodby, R. A. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00269.x · Cited by 92 · see citing works

How Should Nephrologists Approach Gadolinium-based Contrast Imaging in Patients with Kidney Disease?

Perazella, M. A. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00670208 · Cited by 23 · see citing works

Editorial How Should Nephrologists Approach Gadolinium-based Contrast Imaging in Patients with Kidney Disease?

Perazella, M. A. (2015)